AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39

Authors: Nezu, JI Tamai, I Oku, A Ohashi, R Yabuuchi, H Hashimoto, N Nikaido, H Sai, A Koizumi, K Shoji, Y Takada, G Matsuishi, T Yoshino, M Kato, H Ohura, T Tsujimoto, G Hayakawa, J Shimane, M Tsuji, A
Citation: Ji. Nezu et al., Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter, NAT GENET, 21(1), 1999, pp. 91-94

Authors: Tanabe, S Shishido, Y Nakayama, Y Furushiro, M Hashimoto, S Terasaki, T Tsujimoto, G Yokokura, T
Citation: S. Tanabe et al., Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems, PHARM BIO B, 63(4), 1999, pp. 549-553

Authors: Takada, T Yoshida, K Nakamura, K Nakao, K Tsujimoto, G Katsuki, I Sugano, S
Citation: T. Takada et al., Expression of green fluorescent protein in transgenic mice, METH ENZYM, 302, 1999, pp. 233-250

Authors: Tanabe, S Shimohigashi, Y Nakayama, Y Makino, T Fujita, T Nose, T Tsujimoto, G Yokokura, T Naito, M Tsuruo, T Terasaki, T
Citation: S. Tanabe et al., In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog, J PHARM EXP, 290(2), 1999, pp. 561-568

Authors: Koike, M Awaji, T Kataoka, M Tsujimoto, G Kartasova, T Koike, A Shiomi, T
Citation: M. Koike et al., Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis, J CELL SCI, 112(22), 1999, pp. 4031-4039

Authors: Xu, ZJ Hirasawa, A Shinoura, H Tsujimoto, G
Citation: Zj. Xu et al., Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein, J BIOL CHEM, 274(30), 1999, pp. 21149-21154

Authors: Kikuchi, S Tanoue, A Goda, N Matsuo, N Tsujimoto, G
Citation: S. Kikuchi et al., Structure and sequence of the mouse V1a and V1b vasopressin receptor genes, JPN J PHARM, 81(4), 1999, pp. 388-392

Authors: Arai, K Tanoue, A Goda, N Takeda, M Takahashi, K Tsujimoto, G
Citation: K. Arai et al., Characterization of the mouse alpha 1D-adrenergic receptor gene, JPN J PHARM, 81(3), 1999, pp. 271-278

Authors: Takei, R Ikegaki, I Shibata, K Tsujimoto, G Asano, T
Citation: R. Takei et al., Naftopidil, a novel alpha(1)-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha(1)-adrenoceptors, JPN J PHARM, 79(4), 1999, pp. 447-454

Authors: Kataoka, M Kosono, S Tsujimoto, G
Citation: M. Kataoka et al., Spatial and temporal regulation of protein expression by bldA within a Streptomyces lividans colony, FEBS LETTER, 462(3), 1999, pp. 425-429

Authors: Takei, Y Yamamoto, K Tsujimoto, G
Citation: Y. Takei et al., Identification of the sequence responsible for the nuclear localization ofhuman Cdc6, FEBS LETTER, 447(2-3), 1999, pp. 292-296

Authors: Ohmi, K Shinoura, H Nakayama, Y Goda, N Tsujimoto, G
Citation: K. Ohmi et al., Characterization of alpha(1)-adrenoceptors expressed in a novel vascular smooth muscle cell line cloned from p53 knockout mice, P53LMAC01 (AC01) cells, BR J PHARM, 127(3), 1999, pp. 756-762

Authors: Moriyama, N Yamaguchi, T Takeuchi, T Sakamoto, E Ueki, T Tsujimoto, G Kawabe, K
Citation: N. Moriyama et al., Semiquantitative evaluation of alpha(1a)-adrenoceptor subtype mRNA in human hypertrophied and non-hypertrophied prostates: Regional comparison, LIFE SCI, 64(3), 1998, pp. 201-210

Authors: Yamamura, Y Nakamura, S Itoh, S Hirano, T Onogawa, T Yamashita, T Yamada, Y Tsujimae, K Aoyama, M Kotosai, K Ogawa, H Yamashita, H Kondo, K Tominaga, M Tsujimoto, G Mori, T
Citation: Y. Yamamura et al., OPC-41061, a highly potent human vasopressin V-2-receptor antagonist: Pharmacological profile and aquaretic effect by single and multiple oral dosingin rats, J PHARM EXP, 287(3), 1998, pp. 860-867
Risultati: 1-25 | 26-39 |